ETON — Eton Pharmaceuticals, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1710340 ·
Last close
$63.65
Market Cap
$1.84B
52W High
$70.64
52W Low
$14.27
ADV30
569,999
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 57,925,000 44,301,000 23,013,000 35,249,000 157,273,000 55,628,000 70,350,000
Jun 2026 37,589,000 25,413,000 12,794,000 11,578,000 115,807,000 26,845,000 69,222,000
Mar 2026 24,266,000 14,735,000 2,414,000 1,554,000 97,710,000 19,661,000 67,095,000
Dec 2025 21,281,000 13,100,000 2,464,000 1,483,000 92,114,000 25,942,000 65,960,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$15,135,000
Investing CF
$-15,403,000
Financing CF
$1,734,000
CapEx
$-15,124,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.38
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-99,362,000
Inventory
$10,143,000
Receivables
$24,886,000
ST Investments
—
EBIT TTM
$16,309,000
Pretax Income TTM
$12,751,000
Interest Exp TTM
$3,552,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$141,060,992
EBITDA
$47,665,000
Free Cash Flow
$8,321,625
Enterprise Value
$1,596,889,472
Total Cash
$55,628,000
Total Debt
$24,086,000
Shares Out
28,842,215
Trailing EPS
$1.54
Book Value
$3.02
ROE
90.6%
ROA
20.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 79,950,000 -844,000 -4,601,000 92,114,000 65,960,000 26,154,000 10,524,000
Dec 2024 39,011,000 -2,597,000 -3,823,000 76,123,000 51,695,000 24,428,000 969,000
Dec 2023 31,642,000 -1,192,000 -936,000 31,740,000 16,263,000 15,477,000 6,815,000
Dec 2022 21,251,000 -8,260,000 -9,021,000 25,030,000 11,952,000 13,078,000 4,821,000

TTM Snapshot

Revenues TTM
$105,595,000
NetIncome TTM
$12,688,000
OpCashFlow TTM
—
Assets (Latest)
$115,807,000
Forward EPS
$3.31

Peers — same industry

TickerNameMarket CapLastDaily %
TRAX First Tracks Biotherapeutics, Inc. $1.83B $43.57 —
HMDCF HUTCHMED (China) Ltd $1.88B $2.16 —
ZBIO Zenas BioPharma, Inc. $1.88B $27.75 —
AGIO AGIOS PHARMACEUTICALS, INC. $1.79B $29.89 —
ZYME Zymeworks Inc. $1.78B $25.84 —

News headlines (Yahoo Finance, 1h cache)

Explosive Growth Ignites This Biotech. But There's A Catch.
2026-11-18 21:07 · Yahoo
Eton Pharmaceuticals (ETON) Stock Looks Above Fair Value On Earnings
2026-11-11 13:07 · Yahoo
Eton Pharmaceuticals (ETON) Unveils ET 900 And Shares Early ET 700 Clinical Data
2026-11-11 12:14 · Yahoo
Is Eton Pharmaceuticals (ETON) Still Below Fair Value As Earnings And Guidance Impress?
2026-11-11 05:16 · Yahoo
Eton Q3 Earnings Call Highlights Growth and Pipeline Expansion
2026-11-06 08:27 · Yahoo
Eton Pharma (ETON) Q3 2026 Earnings Call Transcript
2026-11-06 07:29 · Yahoo
Eton Pharmaceuticals Inc (ETON) (Q3 2026) Earnings Call Highlights: Record Revenue, Raised ...
2026-11-06 07:22 · Yahoo
Eton Pharmaceuticals, Inc. (ETON) Q3 Earnings and Revenues Surpass Estimates
2026-11-06 00:00 · Yahoo
Eton Pharmaceuticals Reports Third Quarter 2026 Financial Results
2026-11-05 21:05 · Yahoo
Eton Pharmaceuticals Announces Preliminary ET-700 Pilot Study Results Evaluating Copper Absorption Inhibition and Gastrointestinal Tolerability
2026-11-05 21:01 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.